Shaikh Wiqar A, Shaikh Shifa Wiqar
Allergy and Asthma Clinic, Mumbai 400007.
J Indian Med Assoc. 2009 Jul;107(7):462-3.
There are no studies in Indian literature on compliance to various medications for allergic diseases such as nasal sprays, inhalers, immunotherapy and antihistamines. This study was initiated to cover this lacuna. Eighty young patients suffering from asthma with rhinitis or urticaria between the age group of 10 and 40 years were included in this study. Compliance to medications was carefully observed using dose diaries for a period of one year. The data obtained revealed the highest compliance for sublingual immunotherapy (84.19%) and the lowest for a nasal spray (62.32%). The compliance for a dry powder inhaler was 69.31% and for fexofenadine tablets it was 71.78%. These figures are surprisingly low, especially since this study was conducted in a private clinic.
印度文献中没有关于使用各种药物治疗过敏性疾病(如鼻喷雾剂、吸入器、免疫疗法和抗组胺药)的依从性的研究。开展这项研究是为了填补这一空白。本研究纳入了80名年龄在10至40岁之间患有哮喘合并鼻炎或荨麻疹的年轻患者。使用剂量日记对药物依从性进行了为期一年的仔细观察。获得的数据显示,舌下免疫疗法的依从性最高(84.19%),鼻喷雾剂的依从性最低(62.32%)。干粉吸入器的依从性为69.31%,非索非那定片的依从性为71.78%。这些数字低得惊人,特别是因为这项研究是在一家私人诊所进行的。